Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Safety, Tolerability and Efficacy Study of Nalmefene, as Needed Use, in Patients With Alcohol Dependence.

Next Previous
X
Search
Trial Profile

A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Safety, Tolerability and Efficacy Study of Nalmefene, as Needed Use, in Patients With Alcohol Dependence.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 17 Sep 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nalmefene (Primary)
  • Indications Alcohol withdrawal
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms SENSE
  • Sponsors Lundbeck A/S

    • Most Recent Events

    • 09 Jun 2016 Results of a predictive microsimulation model assessing public health benefits of nalmefene and psychosocial support for the reduction of alcohol consumption from ESENSE1, ESENSE2 and SENSE trials published in the Applied Health Economics and Health Policy
    • 21 Oct 2014 Results for a subgroup of patients with comorbid mood disorders presented at the 27th Annual Congress of the European College of Neuropsychopharmacology.
    • 09 Oct 2013 Results for subgroup of patients with a high drinking risk level presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top